Company / Revenue per Share
AbCellera Biologics Inc. Revenue per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.25
FY2025
5-year range
$0.04 / $0.82
FY2021-FY2025
Trend
+156.2%
vs FY2024
Sector context
#124 of 154
Health Care
What the data says
AbCellera Biologics Inc.'s revenue per share of $0.25 is lower than 81% of companies in the Health Care sector (FY2025). Revenue per Share returned to growth in FY2025 after 2 years of decline, reaching $0.25.
Based on SEC 10-K filings.
0.25 in FY2025 with a 5-year CAGR of -22.1%.
Improved from $0.13 to $0.25 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -32.4%
- 5-Year CAGR
- -22.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 154This company $0.25 Sector average $10.35
▼
-97.5% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 156.2% year-over-year.
- Ranks #124 out of 154 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2020.
- Lowest revenue per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.25 | +156.2% |
| FY2024 | $0.10 | -25.2% |
| FY2023 | $0.13 | -83.9% |
| FY2022 | $0.82 | +1810.3% |
| FY2021 | $0.04 | -95.1% |
| FY2020 | $0.89 | +1054.7% |
| FY2019 | $0.08 | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026